These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 27222470)

  • 21. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCG constitutively expressing the adenylyl cyclase encoded by Rv2212 increases its immunogenicity and reduces replication of M. tuberculosis in lungs of BALB/c mice.
    Pedroza-Roldán C; Marquina-Castillo B; Mata-Espinosa D; Barrios-Payán J; Aceves-Sánchez MJ; Hernández Pando R; Flores-Valdez MA
    Tuberculosis (Edinb); 2018 Dec; 113():19-25. PubMed ID: 30514503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.
    Siddiqui KF; Amir M; Khan N; Rama Krishna G; Sheikh JA; Rajagopal K; Agrewala JN
    Clin Exp Immunol; 2015 Aug; 181(2):286-96. PubMed ID: 25845290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved protection against disseminated tuberculosis by Mycobacterium bovis bacillus Calmette-Guerin secreting murine GM-CSF is associated with expansion and activation of APCs.
    Ryan AA; Wozniak TM; Shklovskaya E; O'Donnell MA; Fazekas de St Groth B; Britton WJ; Triccas JA
    J Immunol; 2007 Dec; 179(12):8418-24. PubMed ID: 18056388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Mycobacterium bovis BCG vaccination on cellular immune response of guinea pigs challenged with Mycobacterium tuberculosis.
    Ordway D; Henao-Tamayo M; Shanley C; Smith EE; Palanisamy G; Wang B; Basaraba RJ; Orme IM
    Clin Vaccine Immunol; 2008 Aug; 15(8):1248-58. PubMed ID: 18508930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of local and circulating bovine γδ T cell responses to respiratory BCG vaccination.
    Guerra-Maupome M; McGill JL
    Sci Rep; 2019 Nov; 9(1):15996. PubMed ID: 31690788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guérin Danish: significant protection against infection at 12, but not 24, months.
    Thom ML; McAulay M; Vordermeier HM; Clifford D; Hewinson RG; Villarreal-Ramos B; Hope JC
    Clin Vaccine Immunol; 2012 Aug; 19(8):1254-60. PubMed ID: 22718125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective delipidation of Mycobacterium bovis BCG enables direct pulmonary vaccination and enhances protection against Mycobacterium tuberculosis.
    Moliva JI; Hossfeld AP; Sidiki S; Canan CH; Dwivedi V; Beamer G; Turner J; Torrelles JB
    Mucosal Immunol; 2019 May; 12(3):805-815. PubMed ID: 30778118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo.
    Pedroza-Roldán C; Guapillo C; Barrios-Payán J; Mata-Espinosa D; Aceves-Sánchez Mde J; Marquina-Castillo B; Hernández-Pando R; Flores-Valdez MA
    Vaccine; 2016 Sep; 34(40):4763-70. PubMed ID: 27546876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system.
    Majlessi L; Brodin P; Brosch R; Rojas MJ; Khun H; Huerre M; Cole ST; Leclerc C
    J Immunol; 2005 Mar; 174(6):3570-9. PubMed ID: 15749894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination of cattle with a high dose of BCG vaccine 3 weeks after experimental infection with Mycobacterium bovis increased the inflammatory response, but not tuberculous pathology.
    Buddle BM; Shu D; Parlane NA; Subharat S; Heiser A; Hewinson RG; Vordermeier HM; Wedlock DN
    Tuberculosis (Edinb); 2016 Jul; 99():120-127. PubMed ID: 27450013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain.
    Marcus SA; Steinberg H; Talaat AM
    Vaccine; 2015 Oct; 33(42):5633-5639. PubMed ID: 26363381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial.
    Grode L; Ganoza CA; Brohm C; Weiner J; Eisele B; Kaufmann SH
    Vaccine; 2013 Feb; 31(9):1340-8. PubMed ID: 23290835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.
    Hu Z; Wong KW; Zhao HM; Wen HL; Ji P; Ma H; Wu K; Lu SH; Li F; Li ZM; Shu T; Xu JQ; Lowrie DB; Fan XY
    Mol Ther; 2017 May; 25(5):1222-1233. PubMed ID: 28342639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice.
    Aldwell FE; Tucker IG; de Lisle GW; Buddle BM
    Infect Immun; 2003 Jan; 71(1):101-8. PubMed ID: 12496154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manipulation of BCG vaccine: a double-edged sword.
    Singh VK; Srivastava R; Srivastava BS
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):535-43. PubMed ID: 26810060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
    Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
    Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.